Lumos Diagnostics Holdings Ltd (LDX) — Capital Reinvestment Ratio

Latest as of December 2025: 0.24x

Lumos Diagnostics Holdings Ltd (LDX) has a Capital Reinvestment Ratio of 0.24x as of December 2025, meaning it reinvests 0% of its operating cash flow (AU$778.03K) in capital expenditures (AU$189.41K). Check Lumos Diagnostics Holdings Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.24x
Capex / Operating Cash Flow

Operating Cash Flow

AU$778.03K
AUD

Capital Expenditures

AU$189.41K
AUD

Data as of

Dec 2025
Most recent filing

Lumos Diagnostics Holdings Ltd Capital Reinvestment Ratio (2023–2023)

This chart tracks Lumos Diagnostics Holdings Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Lumos Diagnostics Holdings Ltd cash flow conversion.

Annual Capital Reinvestment Ratio for Lumos Diagnostics Holdings Ltd (2023–2023)

Year-by-year Capital Reinvestment Ratio for Lumos Diagnostics Holdings Ltd from 2023 to 2023. See free cash flow generation of Lumos Diagnostics Holdings Ltd to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2023 0.10x AU$946.00K AU$98.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow